CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [[***]], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL, AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED AND is the type that the registrant treats as...And Program Transfer Agreement • November 8th, 2022 • Atara Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
This Termination, Amendment and Program Transfer Agreement (“Agreement”) is entered into as of the date of the last signature below (“Agreement Effective Date”) by and between:
